Infant, Very Low Birth WeightNCT02078687
Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition
A study testing Enfamil HM fortifier, Mead Johnson, Enfalac Premature Formula, Mead Johnson Nutritionals and Mothers own milk in people with Infant, Very Low Birth Weight and Metabolic Syndrome, Protection Against, run by University of Southern Denmark at 1 site in Denmark.
Trial summary
This is a follow-up cohort study of 6 years old children born preterm in Denmark from 2004-2008, and at four different neonatal units. During hospitalisation they received breast milk with fortification. Read more about this study
- Who is it for?
- Ages 6 to 8 years
- Conditions the study is for
- Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy
- What is being tested?
- Enfamil HM fortifier, Mead Johnson, Enfalac Premature Formula, Mead Johnson Nutritionals and Mothers own milk
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 239 participants
- Where
- 1 siteDenmark
- Study dates
- Oct 2010to Jun 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 8 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Participated in the original study when they were discharge from hospital
- Parents accept of participation in the 6 year follow-up
Who cannot join
- Participation not accepted by parents
- Genetic diseases with influence on growth
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Nutrition in the First Four Month After Hospital Discharge
This is a follow-up cohort study of 6 years old children born preterm in Denmark from 2004-2008, and at four different neonatal units. During hospitalisation they received breast milk with fortification. At time of discharge there were made 3 different nutrition groups; if possible they were randomised into one of two groups:
- Breastfeeding solely
- Breastfeeding with fortification If breastfeeding was not possible they were put in group 3 and were bottle fed with:
- Preterm formula
This nutrition intervention went on for 4 month. At the age of 6, the children will be invited to come for an ambulant control and other examinations regarding growth, allergy and metabolic syndrome.
Read the detailed description
Project background:
The study is based on a follow-up of a cohort of very preterm infants born before week 32, as at discharge from the neonatal departments were randomized to a protein supplement or not while breastfeeding after discharge. If the preterm child was not breastfed, it received a premature infant formula after discharge. Since we have three groups of prematures, which are fed differently after discharge, it is useful to follow up at 6 years of age and specifically examine the following areas:
Metabolic syndrome:
Unlike the past, the survival rate of very preterm infants is now high. Most is expected to survive. The question is the extent to which these children have increased morbidity compared with children born at term, and their quality of life is affected by the fact that they are born prematurely. There has previously been shown a link between children born SGA and later development of type 2 diabetes mellitus, hypertension, ischemic heart disease and cerebrovascular disasters. Too rapid catch-up growth also increases the possible risk of developing metabolic syndrome in the mature child. The question is whether this is also the case in children born prematurely and whether the risk is the same. The problem is just that you want to provide them with adequate amino acids for protein synthesis, as they approach the growth of peers fetuses and also ensure the development of the brain with essential fatty acids, but maybe they can not tolerate a too rapid "catch-up" - growth.
A study comparing preterm born children aged 4-10 years with mature children born of the same age found that the group with preterm births had increased systolic and diastolic blood pressure and higher insulin levels. This was true regardless of whether the children were born SGA and AGA at birth. This concluded that there were metabolic abnormalities in preterm similar to those found in children born at term but SGA. The same article mentions the concept of "fetal programming". This covers a hypothesis which suggests that a fetus at risk in the uterus will adapt best to survive, and this adjustment will be permanent.
The same team has published an article, which have found impaired insulin sensitivity in preterm infants (SGA and AGA) compared to mature AGA children. Insulin sensitivity is greatest in the mature AGA. Next comes the mature SGA and eventually the premature. To show the importance of this area, they point out that out of those who have diabetes mellitus type 2, 35% has had low birth weight.
In trying to find a way it will be interesting, and very relevant, to see if diet the first months of life have an impact on these metabolic complications later in life.
Allergy:
It is unknown whether preterms are at increased risk of developing allergic symptoms. Breastfeeding reduces the risk of developing allergic diseases, while cow milk-based infant formulas increase the risk. The preterm infants in this study completed during hospitalization with fortifier containing cow's milk protein, and the preterm infant formula is cow milk based. It is therefore interesting to see if there is an increased incidence of allergic symptoms in one of the groups. An article formed on the basis of a study of two groups of children, one group consisted of children with a birth weight less than 1500 g, and the second group consisted of children with a birth weight over 2500 g, describes that there was no difference in the incidence of atopy. Another study studied the incidence of food allergies in an area of 13,980 children, and found that 4.23 % were diagnosed with this at the age of six. There was no difference in the incidence of categorization in GA.
The first study mentioned above studied also the appearance of wheezing. This was done using spirometry. The result was that the lifetime risk of preterm births was 43% for developing wheezing, while it was only 17% in mature births. Besides wheezing low GA at birth was associated with decreased lung capacity, reduced forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) and asthma. A relevant question is whether children develop these respiratory symptoms solely on the basis that they are born preterm or nutritional type influences the risk of its development.
Growth and catch-up:
Some studies have gradually studied prematurely born children's growth compared to some control children - especially in the first period after discharge from the neonatal units. As we know, human milk has the best composition in relation to children's needs. There has been made a study on nutrition of preterms with human milk against fortified human milk which states that those who get pure milk, are at greatest risk of malnutrition by discharge and that it is a good strategy to provide breast milk multinutrient enrichment. In the study mothers milked out half of their daily quantity for enrichment. Though, they request long-term studies to determine the long-term effects of it.
Other studies have followed prematurely born children up to 20 years of age and 11 years of age and were compared with a control group of normal weight, not preterm births. Outcome was height, weight, BMI. In one case also head circumference. One study concludes that all very low birthweight children (VLBW) were smaller than the control group. In particular SGA boys were smaller. The second study concluded that extremely immature children have poor growth in early childhood, but they have catch-up until 11 years of age. All prematures remain less than the control group.
A comparison of both nutrition after discharge and follow-up beyond 1 year of age will be very interesting to be able to optimize nutrition and growth of extremely premature infants, both AGA and SGA.
A dual-energy X-ray absorptiometry (DEXA) scan is a study that reveals body composition of bone, muscle and fat. A study of whether the scanning can be used to detect body composition, concluded that DEXA is a good tool for this. It is a quick (minutes) survey that provides minimal radiation, and it is interesting because a scan of the 3 groups in this project will elucidate whether there is a difference in body composition and thus whether a nutritional type provides better basis for the best growth. The same study, which was built on an RCT (randomized controlled trial) of 33 children with GA less than 35 weeks and a birth weight below 1,750 grams who received either 1) standard replacement or 2) enriched compensation for 2 months after discharge, found no difference in body composition or weight gain. It calls for larger studies with longer follow-up. Another study, just as this PhD project, divide the children into several groups depending on Nutrition (1: enriched substitute 2: standard replacement 3: human breast milk), found by DEXA scanning at 6 months of age, group 1 had lower fat mass and group 3 had lower lean (muscle) mass and higher fat mass. So, there is a difference in body composition depending on nutrition. It may sound logical, but will it affect children later in life? - and if so, in what way? From the above examples of previous studies, one can conclude that the optimal nutrition of preterms is under development and there is a continued lack of clarification of how preterm infants grow after discharge and whether one type of nutrition is better.
Hypotheses:
- Nutrition after discharge does affect premature children's growth in the first years of life.
- Catch-up growth proceeds after 1 year of age.
- The growth pattern for prematures born SGA is different from prematures born AGA.
- There is no increase in allergies between prematures, who was fed with premature formula or enriched mothers milk before and after discharge compared with mothers milk without enrichment.
- Premature children fed with a preterm formula have an extended risk for developing metabolic syndrome on basis of excessive growth the first months of life.
- It is possible that premature SGA children have greater risks of developing metabolic syndrome on the basis of excessive growth the first month of life.
- Fat mass and lean mass vary among prematures depending on the nutrition the first month after discharge.
Purpose of the project:
- Investigate whether there are long-term effect on growth after cessation of enrichment of breast milk in 2, 3 and 6 years of age.
- Examine the relationship between protein intake to 4 months of age (corrected) and blood pressure, HbA1c and serum cholesterol by 6 years of age.
- Uncover the incidence of allergy symptoms from the eyes and nose, skin, stomach / intestinal and respiratory tract incl affected lung function in children born prematurely.
- Elucidate whether there is an increased risk of metabolic syndrome in children born prematurely and nourished in different ways.
- Investigate whether preterms have different fat distribution and nutrition up to 4 months corrected age affect them.
- Illuminate catch-up growth in children born prematurely and up to 6 years of age.
Planned studies:
- Weight, height, head circumference, blood pressure
- Registration of any allergy symptoms and airway symptoms.
- Blood tests for diabetes, screening for metabolic syndrome and allergies.
- Questionaires to investigate allergy symptoms.
- A dexa scan to see the body composition of fat, muscle and bone.
Randomization:
The children were randomized when they could eat (breast or bottle) at gestational age 34-42. Twins and triplets were randomly assigned to the same group.
At randomization an impartial person in the department the child was hospitalized in, pulled an envelope with information on what kind of nutrition, the child should have after discharge and up to 4 months of corrected age.
Statistics:
Originally, there were strength calculations prior to randomization in the project. This showed that there were needed 85 children in each feeding group. A total of 320 children in the original project were enrolled. However, there has been a waiver until 1 year of age, and there are 278 children remaining to follow-up.
Wilcoxon rank-sum test or t-test for continuous variables, and if categorical variables chi2test will be used to compare the nutritional groups.
Multiple logistic regression models will be used to compare the clinical relevant variables that have possible influence on the growth of various dietary groups.
Growth will be analyzed from Z-score and delta z-score and will be calculated from a relevant reference for comparing nutritional groups growth.
Allergy risks and metabolic syndrome will be calculated using the above methods and odds ratio.
Project Period:
From 2004 - 2008 there were formed three groups of preterm children at clinical randomization. A Ph.D. dissertation was made subsequently dealing with preterm growth up to 1 year of age, nutrition and composition of breast milk of mothers of preterm babies.
Between the ages of 2 and 3 years, children have come to control for a follow-up Ph.D. The children become 6 years from July 2010 - 2014, where they also will be invited to a follow-up check on the current Ph.D. project.
The children will be followed up in their respective departments / hospitals in Kolding, Skejby, Holbæk and Odense.
Ethical considerations:
For inclusion in the randomized controlled study parents signed an acceptance which included follow-up at 6 years of age.
The initial randomized controlled study was approved by the Ethics Committee 1 July 2004 (J. Nr.VF20030208). As part of the 6-year follow-up, there is added and approved Protocol 1-8.
In addition, permission from the Data Inspectorate of the original project with change in 2007 (J. No 2007-41-1349) is extended until 2016.
- Conditions
- Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy, Dietary Modification
- Being tested
- Enfamil HM fortifier, Mead Johnson, Enfalac Premature Formula, Mead Johnson Nutritionals, Mothers own milk
- Keywords
- very preterm, nutrition, 6 year follow-up, growth, metabolic syndrome, allergy, dexa
- Medical subject headings
- Metabolic Syndrome, Hypersensitivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Enfamil HM fortifier, Mead JohnsonDietary supplement
Also called Enfamil HM fortifier, Mead Johnson, Njimegen, Netherlands
Enfamil was added to a small amount of mothers expressed milk and given in a bottle or with a small cup every day. Group 2 (HMF) received 5 packets each day for 4 month containing; 17.5 kcal, 1.375 g protein/ 5 packets
Enfalac Premature Formula, Mead Johnson NutritionalsDietary supplement
Also called Enfalac PF, Mead Johnson Nutritionals, Njimegen, Netherlands
Group 3 received Enfalac containing:
68 kcal, 2 g protein, 7.4 g carbohydrate, 3.5 g fat/ 100 ml
Mothers own milkDietary supplement
Group 1 received mothers own milk without fortification
| Study group | Role | What they receive |
|---|---|---|
| Group 1, HM | Active comparator | This group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk. Receives: Dietary Supplement: Mothers own milk |
| Group 2, HMF | Active comparator | This group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson. Receives: Dietary Supplement: Enfamil HM fortifier, Mead Johnson; Dietary Supplement: Mothers own milk |
| Group 3, PF | Active comparator | This group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals Receives: Dietary Supplement: Enfalac Premature Formula, Mead Johnson Nutritionals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Growth
Measurement of weight at 6 years corrected age
Measured: Follow-up at approximately 6 years corrected age
Secondary outcomes (1)
Metabolic syndrome
Dexa scan including fat mass, muscle mass, bone mass and Body Mass Index.
Measured: Follow-up at approximately 6 years corrected age
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2014 (estimated)
- Study startOct 2010
- Primary completionApr 2015
- Study completionJun 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Infant, Very Low Birth WeightStudies of the same condition, open and under way.
- More trials run by University of Southern DenmarkThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 239 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Southern Denmark
- Sponsor type
- University, hospital or other
- Collaborators
- Aarhus University Hospital, Holbaek Sygehus, Kolding Sygehus
- Responsible party
- Principal investigator, Line Toftlund, University of Southern Denmark
- Investigators
- Gitte Zachariassen, Specialist, Study director, HC Anderson Children´s Hospital, OUH, DenmarkSusanne Halken, Professor, Study chair, HC Anderson children´s Hospital, OUH, DenmarkLone Agertoft, Specialist, Study director, HC Anderson children´s Hospital, OUH, DenmarkLine H Toftlund, MD, Principal investigator, HC Anderson children´s Hospital, OUH, Denmark
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02078687
- Sponsor's protocol ID
- SDU-2014-LHT
- Status last verified
- Oct 2016
- First submitted
- 28 Feb 2014
- Last updated
- 27 Oct 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998 Aug;95(2):115-28.
PubMed 9680492Hofman PL, Regan F, Harris M, Robinson E, Jackson W, Cutfield WS. The metabolic consequences of prematurity. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S136-9. doi: 10.1016/j.ghir.2004.03.029.
PubMed 15135796Amesz EM, Schaafsma A, Cranendonk A, Lafeber HN. Optimal growth and lower fat mass in preterm infants fed a protein-enriched postdischarge formula. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):200-7. doi: 10.1097/MPG.0b013e3181a8150d.
PubMed 19881394Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med. 2004 Nov 18;351(21):2179-86. doi: 10.1056/NEJMoa042275.
PubMed 15548778Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004 Jan;37(1):43-9. doi: 10.1002/ppul.10402.
PubMed 14679488Liem JJ, Kozyrskyj AL, Huq SI, Becker AB. The risk of developing food allergy in premature or low-birth-weight children. J Allergy Clin Immunol. 2007 May;119(5):1203-9. doi: 10.1016/j.jaci.2006.12.671. Epub 2007 Mar 26.
PubMed 17379288G. Zachariassen, J Færk mf. Nutrient-enrichment of human milk for preterm infants after hospital discharge - a randomized controlled trial. Pediatrics 2010.
O'Connor DL, Khan S, Weishuhn K, Vaughan J, Jefferies A, Campbell DM, Asztalos E, Feldman M, Rovet J, Westall C, Whyte H; Postdischarge Feeding Study Group. Growth and nutrient intakes of human milk-fed preterm infants provided with extra energy and nutrients after hospital discharge. Pediatrics. 2008 Apr;121(4):766-76. doi: 10.1542/peds.2007-0054.
PubMed 18381542Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003 Jul;112(1 Pt 1):e30-8. doi: 10.1542/peds.112.1.e30.
PubMed 12837903Farooqi A, Hagglof B, Sedin G, Gothefors L, Serenius F. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study. Pediatrics. 2006 Nov;118(5):e1452-65. doi: 10.1542/peds.2006-1069.
PubMed 17079546De Curtis M, Pieltain C, Rigo J. Body composition in preterm infants fed standard term or enriched formula after hospital discharge. Eur J Nutr. 2002 Aug;41(4):177-82. doi: 10.1007/s00394-002-0374-2.
PubMed 12242586Zachariassen G, Faerk J, Grytter C, Esberg BH, Hjelmborg J, Mortensen S, Thybo Christesen H, Halken S. Nutrient enrichment of mother's milk and growth of very preterm infants after hospital discharge. Pediatrics. 2011 Apr;127(4):e995-e1003. doi: 10.1542/peds.2010-0723. Epub 2011 Mar 14.
PubMed 21402642Zachariassen G, Faerk J, Esberg BH, Fenger-Gron J, Mortensen S, Christesen HT, Halken S. Allergic diseases among very preterm infants according to nutrition after hospital discharge. Pediatr Allergy Immunol. 2011 Aug;22(5):515-20. doi: 10.1111/j.1399-3038.2010.01102.x. Epub 2011 Feb 20.
PubMed 21332800Toftlund LH, Halken S, Agertoft L, Zachariassen G. Early nutrition and signs of metabolic syndrome at 6 y of age in children born very preterm. Am J Clin Nutr. 2018 May 1;107(5):717-724. doi: 10.1093/ajcn/nqy015.
PubMed 29722837
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Nutrition in the First Four Month After Hospital Discharge
- ClinicalTrials.gov ID
- NCT02078687
- Acronym / sponsor ID
- SDU-2014-LHT
- Conditions
- Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy, Dietary Modification
- Keywords
- very preterm, nutrition, 6 year follow-up, growth, metabolic syndrome, allergy, dexa
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 239 participants (actual)
- Lead sponsor
- University of Southern DenmarkUniversity, hospital or other
- Collaborators
- Aarhus University Hospital, Holbaek Sygehus, Kolding Sygehus
- Study start
- Oct 2010
- Primary completion
- Apr 2015 (actual)
- Study completion
- Jun 2016 (actual)
- First posted
- 5 Mar 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a follow-up cohort study of 6 years old children born preterm in Denmark from 2004-2008, and at four different neonatal units. During hospitalisation they received breast milk with fortification. At time of discharge there were made 3 different nutrition groups; if possible they were randomised into one of two groups:
- Breastfeeding solely
- Breastfeeding with fortification If breastfeeding was not possible they were put in group 3 and were bottle fed with:
- Preterm formula
This nutrition intervention went on for 4 month. At the age of 6, the children will be invited to come for an ambulant control and other examinations regarding growth, allergy and metabolic syndrome.
Detailed description
Project background:
The study is based on a follow-up of a cohort of very preterm infants born before week 32, as at discharge from the neonatal departments were randomized to a protein supplement or not while breastfeeding after discharge. If the preterm child was not breastfed, it received a premature infant formula after discharge. Since we have three groups of prematures, which are fed differently after discharge, it is useful to follow up at 6 years of age and specifically examine the following areas:
Metabolic syndrome:
Unlike the past, the survival rate of very preterm infants is now high. Most is expected to survive. The question is the extent to which these children have increased morbidity compared with children born at term, and their quality of life is affected by the fact that they are born prematurely. There has previously been shown a link between children born SGA and later development of type 2 diabetes mellitus, hypertension, ischemic heart disease and cerebrovascular disasters. Too rapid catch-up growth also increases the possible risk of developing metabolic syndrome in the mature child. The question is whether this is also the case in children born prematurely and whether the risk is the same. The problem is just that you want to provide them with adequate amino acids for protein synthesis, as they approach the growth of peers fetuses and also ensure the development of the brain with essential fatty acids, but maybe they can not tolerate a too rapid "catch-up" - growth.
A study comparing preterm born children aged 4-10 years with mature children born of the same age found that the group with preterm births had increased systolic and diastolic blood pressure and higher insulin levels. This was true regardless of whether the children were born SGA and AGA at birth. This concluded that there were metabolic abnormalities in preterm similar to those found in children born at term but SGA. The same article mentions the concept of "fetal programming". This covers a hypothesis which suggests that a fetus at risk in the uterus will adapt best to survive, and this adjustment will be permanent.
The same team has published an article, which have found impaired insulin sensitivity in preterm infants (SGA and AGA) compared to mature AGA children. Insulin sensitivity is greatest in the mature AGA. Next comes the mature SGA and eventually the premature. To show the importance of this area, they point out that out of those who have diabetes mellitus type 2, 35% has had low birth weight.
In trying to find a way it will be interesting, and very relevant, to see if diet the first months of life have an impact on these metabolic complications later in life.
Allergy:
It is unknown whether preterms are at increased risk of developing allergic symptoms. Breastfeeding reduces the risk of developing allergic diseases, while cow milk-based infant formulas increase the risk. The preterm infants in this study completed during hospitalization with fortifier containing cow's milk protein, and the preterm infant formula is cow milk based. It is therefore interesting to see if there is an increased incidence of allergic symptoms in one of the groups. An article formed on the basis of a study of two groups of children, one group consisted of children with a birth weight less than 1500 g, and the second group consisted of children with a birth weight over 2500 g, describes that there was no difference in the incidence of atopy. Another study studied the incidence of food allergies in an area of 13,980 children, and found that 4.23 % were diagnosed with this at the age of six. There was no difference in the incidence of categorization in GA.
The first study mentioned above studied also the appearance of wheezing. This was done using spirometry. The result was that the lifetime risk of preterm births was 43% for developing wheezing, while it was only 17% in mature births. Besides wheezing low GA at birth was associated with decreased lung capacity, reduced forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) and asthma. A relevant question is whether children develop these respiratory symptoms solely on the basis that they are born preterm or nutritional type influences the risk of its development.
Growth and catch-up:
Some studies have gradually studied prematurely born children's growth compared to some control children - especially in the first period after discharge from the neonatal units. As we know, human milk has the best composition in relation to children's needs. There has been made a study on nutrition of preterms with human milk against fortified human milk which states that those who get pure milk, are at greatest risk of malnutrition by discharge and that it is a good strategy to provide breast milk multinutrient enrichment. In the study mothers milked out half of their daily quantity for enrichment. Though, they request long-term studies to determine the long-term effects of it.
Other studies have followed prematurely born children up to 20 years of age and 11 years of age and were compared with a control group of normal weight, not preterm births. Outcome was height, weight, BMI. In one case also head circumference. One study concludes that all very low birthweight children (VLBW) were smaller than the control group. In particular SGA boys were smaller. The second study concluded that extremely immature children have poor growth in early childhood, but they have catch-up until 11 years of age. All prematures remain less than the control group.
A comparison of both nutrition after discharge and follow-up beyond 1 year of age will be very interesting to be able to optimize nutrition and growth of extremely premature infants, both AGA and SGA.
A dual-energy X-ray absorptiometry (DEXA) scan is a study that reveals body composition of bone, muscle and fat. A study of whether the scanning can be used to detect body composition, concluded that DEXA is a good tool for this. It is a quick (minutes) survey that provides minimal radiation, and it is interesting because a scan of the 3 groups in this project will elucidate whether there is a difference in body composition and thus whether a nutritional type provides better basis for the best growth. The same study, which was built on an RCT (randomized controlled trial) of 33 children with GA less than 35 weeks and a birth weight below 1,750 grams who received either 1) standard replacement or 2) enriched compensation for 2 months after discharge, found no difference in body composition or weight gain. It calls for larger studies with longer follow-up. Another study, just as this PhD project, divide the children into several groups depending on Nutrition (1: enriched substitute 2: standard replacement 3: human breast milk), found by DEXA scanning at 6 months of age, group 1 had lower fat mass and group 3 had lower lean (muscle) mass and higher fat mass. So, there is a difference in body composition depending on nutrition. It may sound logical, but will it affect children later in life? - and if so, in what way? From the above examples of previous studies, one can conclude that the optimal nutrition of preterms is under development and there is a continued lack of clarification of how preterm infants grow after discharge and whether one type of nutrition is better.
Hypotheses:
- Nutrition after discharge does affect premature children's growth in the first years of life.
- Catch-up growth proceeds after 1 year of age.
- The growth pattern for prematures born SGA is different from prematures born AGA.
- There is no increase in allergies between prematures, who was fed with premature formula or enriched mothers milk before and after discharge compared with mothers milk without enrichment.
- Premature children fed with a preterm formula have an extended risk for developing metabolic syndrome on basis of excessive growth the first months of life.
- It is possible that premature SGA children have greater risks of developing metabolic syndrome on the basis of excessive growth the first month of life.
- Fat mass and lean mass vary among prematures depending on the nutrition the first month after discharge.
Purpose of the project:
- Investigate whether there are long-term effect on growth after cessation of enrichment of breast milk in 2, 3 and 6 years of age.
- Examine the relationship between protein intake to 4 months of age (corrected) and blood pressure, HbA1c and serum cholesterol by 6 years of age.
- Uncover the incidence of allergy symptoms from the eyes and nose, skin, stomach / intestinal and respiratory tract incl affected lung function in children born prematurely.
- Elucidate whether there is an increased risk of metabolic syndrome in children born prematurely and nourished in different ways.
- Investigate whether preterms have different fat distribution and nutrition up to 4 months corrected age affect them.
- Illuminate catch-up growth in children born prematurely and up to 6 years of age.
Planned studies:
- Weight, height, head circumference, blood pressure
- Registration of any allergy symptoms and airway symptoms.
- Blood tests for diabetes, screening for metabolic syndrome and allergies.
- Questionaires to investigate allergy symptoms.
- A dexa scan to see the body composition of fat, muscle and bone.
Randomization:
The children were randomized when they could eat (breast or bottle) at gestational age 34-42. Twins and triplets were randomly assigned to the same group.
At randomization an impartial person in the department the child was hospitalized in, pulled an envelope with information on what kind of nutrition, the child should have after discharge and up to 4 months of corrected age.
Statistics:
Originally, there were strength calculations prior to randomization in the project. This showed that there were needed 85 children in each feeding group. A total of 320 children in the original project were enrolled. However, there has been a waiver until 1 year of age, and there are 278 children remaining to follow-up.
Wilcoxon rank-sum test or t-test for continuous variables, and if categorical variables chi2test will be used to compare the nutritional groups.
Multiple logistic regression models will be used to compare the clinical relevant variables that have possible influence on the growth of various dietary groups.
Growth will be analyzed from Z-score and delta z-score and will be calculated from a relevant reference for comparing nutritional groups growth.
Allergy risks and metabolic syndrome will be calculated using the above methods and odds ratio.
Project Period:
From 2004 - 2008 there were formed three groups of preterm children at clinical randomization. A Ph.D. dissertation was made subsequently dealing with preterm growth up to 1 year of age, nutrition and composition of breast milk of mothers of preterm babies.
Between the ages of 2 and 3 years, children have come to control for a follow-up Ph.D. The children become 6 years from July 2010 - 2014, where they also will be invited to a follow-up check on the current Ph.D. project.
The children will be followed up in their respective departments / hospitals in Kolding, Skejby, Holbæk and Odense.
Ethical considerations:
For inclusion in the randomized controlled study parents signed an acceptance which included follow-up at 6 years of age.
The initial randomized controlled study was approved by the Ethics Committee 1 July 2004 (J. Nr.VF20030208). As part of the 6-year follow-up, there is added and approved Protocol 1-8.
In addition, permission from the Data Inspectorate of the original project with change in 2007 (J. No 2007-41-1349) is extended until 2016.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Group 1, HM | Active comparator | Dietary Supplement: Mothers own milkThis group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk. |
| Group 2, HMF | Active comparator | Dietary Supplement: Enfamil HM fortifier, Mead Johnson, Dietary Supplement: Mothers own milkThis group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson. |
| Group 3, PF | Active comparator | Dietary Supplement: Enfalac Premature Formula, Mead Johnson NutritionalsThis group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals |
Who may qualify
- Ages
- 6 to 8 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Participated in the original study when they were discharge from hospital
- Parents accept of participation in the 6 year follow-up
Key exclusion criteria (2 listed)
- Participation not accepted by parents
- Genetic diseases with influence on growth
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Enfamil HM fortifier, Mead JohnsonAlso: Enfamil HM fortifier, Mead Johnson, Njimegen, NetherlandsEnfamil was added to a small amount of mothers expressed milk and given in a bottle or with a small cup every day. Group 2 (HMF) received 5 packets each day for 4 month containing; 17.5 kcal, 1.375 g protein/ 5 packets | Dietary supplement | Group 2, HMF |
| Enfalac Premature Formula, Mead Johnson NutritionalsAlso: Enfalac PF, Mead Johnson Nutritionals, Njimegen, NetherlandsGroup 3 received Enfalac containing: 68 kcal, 2 g protein, 7.4 g carbohydrate, 3.5 g fat/ 100 ml | Dietary supplement | Group 3, PF |
| Mothers own milkGroup 1 received mothers own milk without fortification | Dietary supplement | Group 1, HM, Group 2, HMF |
Primary outcome
Growth
Time frame: Follow-up at approximately 6 years corrected age
Measurement of weight at 6 years corrected age
1 secondary outcome
Metabolic syndrome
Time frame: Follow-up at approximately 6 years corrected age
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2016.
- Background: PubMed 9680492Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998 Aug;95(2):115-28.
- Background: PubMed 15135796Hofman PL, Regan F, Harris M, Robinson E, Jackson W, Cutfield WS. The metabolic consequences of prematurity. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S136-9. doi: 10.1016/j.ghir.2004.03.029.
- Background: PubMed 19881394Amesz EM, Schaafsma A, Cranendonk A, Lafeber HN. Optimal growth and lower fat mass in preterm infants fed a protein-enriched postdischarge formula. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):200-7. doi: 10.1097/MPG.0b013e3181a8150d.
- Background: PubMed 15548778Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med. 2004 Nov 18;351(21):2179-86. doi: 10.1056/NEJMoa042275.
- Background: PubMed 14679488Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004 Jan;37(1):43-9. doi: 10.1002/ppul.10402.
- Background: PubMed 17379288Liem JJ, Kozyrskyj AL, Huq SI, Becker AB. The risk of developing food allergy in premature or low-birth-weight children. J Allergy Clin Immunol. 2007 May;119(5):1203-9. doi: 10.1016/j.jaci.2006.12.671. Epub 2007 Mar 26.
- BackgroundG. Zachariassen, J Færk mf. Nutrient-enrichment of human milk for preterm infants after hospital discharge - a randomized controlled trial. Pediatrics 2010.
- Background: PubMed 18381542O'Connor DL, Khan S, Weishuhn K, Vaughan J, Jefferies A, Campbell DM, Asztalos E, Feldman M, Rovet J, Westall C, Whyte H; Postdischarge Feeding Study Group. Growth and nutrient intakes of human milk-fed preterm infants provided with extra energy and nutrients after hospital discharge. Pediatrics. 2008 Apr;121(4):766-76. doi: 10.1542/peds.2007-0054.
- Background: PubMed 12837903Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003 Jul;112(1 Pt 1):e30-8. doi: 10.1542/peds.112.1.e30.
- Background: PubMed 17079546Farooqi A, Hagglof B, Sedin G, Gothefors L, Serenius F. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study. Pediatrics. 2006 Nov;118(5):e1452-65. doi: 10.1542/peds.2006-1069.
- Background: PubMed 12242586De Curtis M, Pieltain C, Rigo J. Body composition in preterm infants fed standard term or enriched formula after hospital discharge. Eur J Nutr. 2002 Aug;41(4):177-82. doi: 10.1007/s00394-002-0374-2.
- Background: PubMed 21402642Zachariassen G, Faerk J, Grytter C, Esberg BH, Hjelmborg J, Mortensen S, Thybo Christesen H, Halken S. Nutrient enrichment of mother's milk and growth of very preterm infants after hospital discharge. Pediatrics. 2011 Apr;127(4):e995-e1003. doi: 10.1542/peds.2010-0723. Epub 2011 Mar 14.
Related trials for Infant, Very Low Birth Weight
Recruiting
Effect of Developmental Care on Very Low Birth Weight Infants
Intervention
Active, not recruiting
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
Premature Infant, Respiratory Distress Syndrome in Premature Infant
RecruitingPhase 1
Gut Permeability and Microbiome in Preterm Infants
Prematurity Complications
Not yet recruitingObservational study
Predictors of Postnatal Growth Failure in Preterm Infants
Premature Birth, Growth Failure
Recruiting
Donor Breast Milk 2
Iron Deficiency Anemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gitte Zachariassen, Specialist study director
HC Anderson Children´s Hospital, OUH, Denmark
Susanne Halken, Professor study chair
HC Anderson children´s Hospital, OUH, Denmark
Lone Agertoft, Specialist study director
HC Anderson children´s Hospital, OUH, Denmark
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Enfamil HM fortifier, Mead Johnson, Enfalac Premature Formula, Mead Johnson Nutritionals and Mothers own milk in people with Infant, Very Low Birth Weight and Metabolic Syndrome, Protection Against, run by University of Southern Denmark at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Growth (time frame: Follow-up at approximately 6 years corrected age). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02078687, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2016.